590 related articles for article (PubMed ID: 33275674)
1. Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases.
Malpica L; Moll S
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):319-327. PubMed ID: 33275674
[TBL] [Abstract][Full Text] [Related]
2. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG; Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002290. PubMed ID: 32297308
[TBL] [Abstract][Full Text] [Related]
3. Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders.
Malpica L; van Duin D; Moll S
Am J Hematol; 2019 Dec; 94(12):1396-1412. PubMed ID: 31571266
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
5. Prevention and management of the adverse effects associated with immunosuppressive therapy.
Rossi SJ; Schroeder TJ; Hariharan S; First MR
Drug Saf; 1993 Aug; 9(2):104-31. PubMed ID: 8397889
[TBL] [Abstract][Full Text] [Related]
6. Infection Risk and Safety of Corticosteroid Use.
Youssef J; Novosad SA; Winthrop KL
Rheum Dis Clin North Am; 2016 Feb; 42(1):157-76, ix-x. PubMed ID: 26611557
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy.
Yale SH; Limper AH
Mayo Clin Proc; 1996 Jan; 71(1):5-13. PubMed ID: 8538233
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive drug therapy.
McCune WJ; Vallance DK; Lynch JP
Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
[TBL] [Abstract][Full Text] [Related]
10. [Pneumocystis pneumonia among patients with systemic diseases].
Khellaf M; Godeau B
Presse Med; 2009 Feb; 38(2):251-9. PubMed ID: 19062243
[TBL] [Abstract][Full Text] [Related]
11. A case of granulomatosis with polyangiitis complicated by cyclophosphamide toxicity and opportunistic infections: choosing between Scylla and Charybdis.
Ernst E; Girndt M; Pliquett RU
BMC Nephrol; 2014 Feb; 15():28. PubMed ID: 24495297
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?
Liebling M; Rubio E; Ie S
Expert Rev Respir Med; 2015 Apr; 9(2):171-81. PubMed ID: 25771943
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine and therapeutic plasma exchange in treatment of progressive autoimmune diseases.
Schiel R; Bambauer R; Latza R; Klinkmann J
Artif Organs; 1997 Sep; 21(9):983-8. PubMed ID: 9288868
[TBL] [Abstract][Full Text] [Related]
14. [Immunosuppression--a tightrope walk between iatrogenic harm and therapy].
Berchtold P; Seitz M
Schweiz Med Wochenschr; 1996 Sep; 126(38):1603-9. PubMed ID: 8927965
[TBL] [Abstract][Full Text] [Related]
15. Drug therapy. Immunosuppressive agents. I.
Kaplan SR; Calabresi P
N Engl J Med; 1973 Nov; 289(18):952-5. PubMed ID: 4582749
[No Abstract] [Full Text] [Related]
16. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.
Mecoli CA; Saylor D; Gelber AC; Christopher-Stine L
Clin Exp Rheumatol; 2017; 35(4):671-673. PubMed ID: 28134084
[TBL] [Abstract][Full Text] [Related]
17. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Liu ID; Willis NS; Craig JC; Hodson EM
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
[TBL] [Abstract][Full Text] [Related]
18. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Pravitsitthikul N; Willis NS; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2013 Oct; (10):CD002290. PubMed ID: 24166716
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs.
Schmajuk G; Jafri K; Evans M; Shiboski S; Gianfrancesco M; Izadi Z; Patterson SL; Aggarwal I; Sarkar U; Dudley RA; Yazdany J
Semin Arthritis Rheum; 2019 Jun; 48(6):1087-1092. PubMed ID: 30449650
[TBL] [Abstract][Full Text] [Related]
20. [Auto-immune hepatitis: therapeutic management].
Pariente A
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B13-9. PubMed ID: 12843932
[No Abstract] [Full Text] [Related]
[Next] [New Search]
